Positive Results for Hexvix Phase III Clinical Trial in China Presented at the SIU 2023 Congress

Photocure ASA, the Bladder Cancer Company, announces that its partner Asieris Pharmaceuticals has unveiled the results of its Hexvix® Phase III clinical trial in China.